Wirths O - Search Results

1

A microRNA signature that correlates with cognition and is a target against cognitive decline.

Islam MR, Kaurani L, Berulava T, Heilbronner U, Budde M, Centeno TP, Elerdashvili V, Zafieriou MP, Benito E, Sertel SM, Goldberg M, Senner F, Kalman JL, Burkhardt S, Oepen AS, Sakib MS, Kerimoglu C, Wirths O, Bickeböller H, Bartels C, Brosseron F, Buerger K, Cosma NC, Fliessbach K, Heneka MT, Janowitz D, Kilimann I, Kleinedam L, Laske C, Metzger CD, Munk MH, Perneczky R, Peters O, Priller J, Rauchmann BS, Roy N, Schneider A, Spottke A, Spruth EJ, Teipel S, Tscheuschler M, Wagner M, Wiltfang J, Düzel E, Jessen F; Delcode Study Group; Rizzoli SO, Zimmermann WH, Schulze TG, Falkai P, Sananbenesi F, Fischer A. Islam MR, et al. Among authors: wirths o. EMBO Mol Med. 2021 Nov 8;13(11):e13659. doi: 10.15252/emmm.202013659. Epub 2021 Oct 11. EMBO Mol Med. 2021. PMID: 34633146 Free PMC article.

2

Traumatic brain injury: cause or risk of Alzheimer's disease? A review of experimental studies.

Szczygielski J, Mautes A, Steudel WI, Falkai P, Bayer TA, Wirths O. Szczygielski J, et al. Among authors: wirths o. J Neural Transm (Vienna). 2005 Nov;112(11):1547-64. doi: 10.1007/s00702-005-0326-0. Epub 2005 Jun 15. J Neural Transm (Vienna). 2005. PMID: 15959838 Review.

3

Effect of copper intake on CSF parameters in patients with mild Alzheimer's disease: a pilot phase 2 clinical trial.

Kessler H, Pajonk FG, Bach D, Schneider-Axmann T, Falkai P, Herrmann W, Multhaup G, Wiltfang J, Schäfer S, Wirths O, Bayer TA. Kessler H, et al. Among authors: wirths o. J Neural Transm (Vienna). 2008 Dec;115(12):1651-9. doi: 10.1007/s00702-008-0136-2. Epub 2008 Oct 30. J Neural Transm (Vienna). 2008. PMID: 18972062 Clinical Trial.

4

N-truncated Aβ2-X starting with position two in sporadic Alzheimer's disease cases and two Alzheimer mouse models.

Savastano A, Klafki H, Haußmann U, Oberstein TJ, Muller P, Wirths O, Wiltfang J, Bayer TA. Savastano A, et al. Among authors: wirths o. J Alzheimers Dis. 2016;49(1):101-10. doi: 10.3233/JAD-150394. J Alzheimers Dis. 2016. PMID: 26529393

5

Physical activity delays hippocampal neurodegeneration and rescues memory deficits in an Alzheimer disease mouse model.

Hüttenrauch M, Brauß A, Kurdakova A, Borgers H, Klinker F, Liebetanz D, Salinas-Riester G, Wiltfang J, Klafki HW, Wirths O. Hüttenrauch M, et al. Among authors: wirths o. Transl Psychiatry. 2016 May 3;6(5):e800. doi: 10.1038/tp.2016.65. Transl Psychiatry. 2016. PMID: 27138799 Free PMC article.

6

N-truncated Aβ_4-x peptides in sporadic Alzheimer's disease cases and transgenic Alzheimer mouse models.

Wirths O, Walter S, Kraus I, Klafki HW, Stazi M, Oberstein TJ, Ghiso J, Wiltfang J, Bayer TA, Weggen S. Wirths O, et al. Alzheimers Res Ther. 2017 Oct 4;9(1):80. doi: 10.1186/s13195-017-0309-z. Alzheimers Res Ther. 2017. PMID: 28978359 Free PMC article.

7

Glycoprotein NMB: a novel Alzheimer's disease associated marker expressed in a subset of activated microglia.

Hüttenrauch M, Ogorek I, Klafki H, Otto M, Stadelmann C, Weggen S, Wiltfang J, Wirths O. Hüttenrauch M, et al. Among authors: wirths o. Acta Neuropathol Commun. 2018 Oct 19;6(1):108. doi: 10.1186/s40478-018-0612-3. Acta Neuropathol Commun. 2018. PMID: 30340518 Free PMC article.

8

N-terminal heterogeneity of parenchymal and vascular amyloid-β deposits in Alzheimer's disease.

Zampar S, Klafki HW, Sritharen K, Bayer TA, Wiltfang J, Rostagno A, Ghiso J, Miles LA, Wirths O. Zampar S, et al. Among authors: wirths o. Neuropathol Appl Neurobiol. 2020 Dec;46(7):673-685. doi: 10.1111/nan.12637. Epub 2020 Jun 29. Neuropathol Appl Neurobiol. 2020. PMID: 32497293 Free PMC article.

9

Evaluation of cerebrospinal fluid glycoprotein NMB (GPNMB) as a potential biomarker for Alzheimer's disease.

Aichholzer F, Klafki HW, Ogorek I, Vogelgsang J, Wiltfang J, Scherbaum N, Weggen S, Wirths O. Aichholzer F, et al. Among authors: wirths o. Alzheimers Res Ther. 2021 May 4;13(1):94. doi: 10.1186/s13195-021-00828-1. Alzheimers Res Ther. 2021. PMID: 33947460 Free PMC article.

10

Interferon-driven brain phenotype in a mouse model of RNaseT2 deficient leukoencephalopathy.

Kettwig M, Ternka K, Wendland K, Krüger DM, Zampar S, Schob C, Franz J, Aich A, Winkler A, Sakib MS, Kaurani L, Epple R, Werner HB, Hakroush S, Kitz J, Prinz M, Bartok E, Hartmann G, Schröder S, Rehling P, Henneke M, Boretius S, Alia A, Wirths O, Fischer A, Stadelmann C, Nessler S, Gärtner J. Kettwig M, et al. Among authors: wirths o. Nat Commun. 2021 Nov 11;12(1):6530. doi: 10.1038/s41467-021-26880-x. Nat Commun. 2021. PMID: 34764281 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

120 results

Search Page